Benchmark Financial Wealth Advisors, LLC Amgen Inc Transaction History
Benchmark Financial Wealth Advisors, LLC
- $300 Million
- Q2 2025
A detailed history of Benchmark Financial Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Benchmark Financial Wealth Advisors, LLC holds 905 shares of AMGN stock, worth $267,708. This represents 0.08% of its overall portfolio holdings.
Number of Shares
905
Previous 773
17.08%
Holding current value
$267,708
Previous $240,000
5.0%
% of portfolio
0.08%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding AMGN
# of Institutions
3,281Shares Held
441MCall Options Held
6.14MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.68 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.59 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.99 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...